Aggressive Shorting in ARCT
Arcturus Therapeutics (ARCT) has recorded a significant surge in short-selling activity, with a short volume ratio reaching 72% over the last five trading days. This level of short volume is exceptionally high and suggests that the market is heavily betting against the company's near-term prospects. The data, sourced from the FINRA Consolidated NMS short-volume file, confirms that the majority of trading activity in the stock is currently driven by short sellers.
Implications for Traders
Such a high short volume ratio often precedes significant price swings. While the current short interest is high, the extreme daily short volume indicates that the bearish pressure is intensifying. Investors should be cautious, as the high volume of short trades could lead to a rapid price reversal if the stock fails to break lower, forcing short sellers to cover their positions in a crowded market.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.